Nucleic Acids and Precision Therapies for Neuroprotection
Taylor & Francis Ltd
ISBN 978-1-03-268673-8
Standardpreis
Bibliografische Daten
Buch. Hardcover
2026
38 s/w-Abbildungen, 4 Farbabbildungen, 35 s/w-Fotos, 4 Farbfotos, 3 s/w-Zeichnungen, 43 s/w-Tabelle.
Umfang: 488 S.
Format (B x L): 21 x 29.7 cm
Gewicht: 453
Verlag: Taylor & Francis Ltd
ISBN: 978-1-03-268673-8
Produktbeschreibung
Rather than cataloguing modalities in isolation, the book lays out an end-to-end translational roadmap from target identification and sequence optimisation to blood–brain barrier traversal, immunogenicity management, scalable manufacturing, and ethical oversight. Delivery science (including viral, nanoparticle, and hybrid vectors), AI-enabled biomarker discovery, adaptive trial architectures, and shifting global regulatory frameworks are viewed as interlocking elements of a single development pathway.
By aligning disparate scientific “dialects” into a shared, practice-oriented language, Nucleic Acids and Precision Therapies for Neuroprotection offers what the field currently lacks: a cohesive guide for moving nucleic acid therapeutics from concept to clinic with precision. Researchers, clinicians, regulators, and industry teams will find pragmatic frameworks, comparative tables, and decision points that shorten the path between mechanistic insight and patient impact without sacrificing rigour or transparency.
Autorinnen und Autoren
Produktsicherheit
Hersteller
Libri GmbH
Europaallee 1
36244 Bad Hersfeld, DE
gpsr@libri.de
BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS
